Renalytix Plc (RNLXD)

Market Cap	36.53M
Revenue (ttm)	3.00M
Net Income (ttm)	-20.40M
Shares Out	n/a
EPS (ttm)	-0.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,153
Average Volume	3,168
Open	3.926
Previous Close	3.842
Day's Range	3.850 - 3.926
52-Week Range	3.126 - 8.090
Beta	n/a
RSI	37.55
Earnings Date	Dec 17, 2025

About Renalytix

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score. The company’s products are used in kidney disease diagnosis and prognosis, cl...

• Industry: Prepackaged Software
• Founded: 2018
• Employees: 102
• Stock Exchange: OTCMKTS
• Ticker Symbol: RNLXD

Financial Performance

In 2025, Renalytix's revenue was $3.00 million, an increase of 30.43% compared to the previous year's $2.30 million. Losses were -$20.40 million, -55.16% less than in 2024.